Table 1:
Primary studies (case-control) included in the meta-analysis
| Reference | Publication year | Publication language | Case (N) | Control (N) | Type of HPV | Source of sample | OR (95%) | |||
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| Event | Total | Event | Total | Case (%) | Control (%) | |||||
| (16) | 2017 | English | 7 | 50 | 0 | 50 | Not detected | Not detected | SCC | 17.41 (0.97, 313.73) |
| (17) | 2009 | English | 10 | 22 | 5 | 20 | 6,11(30) 6 (60) 18(10) |
6,11(20) 16(80) |
SCC | 2.50 (0.67, 9.31) |
| (18) | 2015 | English | 18 | 155 | 0 | 18 | 6,11 (83.33) 16,18 (16.66) |
Not detected | SCC, VCs, LPs | 4.98 (0.29, 86.12) |
| (19) | 2019 | English | 3 | 30 | 0 | 30 | Not detected | Not detected | OSCC | 7.76 (0.38, 157.14) |
| (20) | 2006 | English | 32 | 100 | 5 | 50 | 6 (31.6) 11 (12.5) 16 (12.5) 31 (3.1) 6,16(6.3) |
Not detected | ameloblastoma | 4.24 (1.53, 11.69) |
| (21) | 2015 | English | 17 | 39 | 0 | 27 | 16,18(12.8) 16 (30.7) |
Not detected | OSCC | 42.78 (2.44, 751.32) |
| (22) | 2003 | English | 20 | 50 | 9 | 50 | 6(40) | Not detected | ameloblastoma | 3.04 (1.21, 7.60) |
| (23) | 2011 | English | 3 | 41 | 0 | 18 | 16,18(7.3) | Not detected | LPs, VCs | 3.36 (0.17, 68.56) |
| Pooled estimate (random model) | 110 | 487 | 19 | 263 | 4.00 (2.31, 6.93) | |||||